Can the early reduction of tumour markers predict outcome in surgically treated sporadic medullary thyroid carcinoma?

Langenbeck's Archives of Surgery

Volumn 393, Issue 5, 2008, Pages 699-703

  Bümming, Per ^a   Ahlman, Håkan ^a   Nilsson, Bengt ^a   Nilsson, Ola ^a   Wängberg, Bo ^a   Jansson, Svante ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Medullary thyroid carcinoma; Outcome; Surgery; Tumour markers

Indexed keywords

CALCITONIN; CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE FREE INTERVAL; FEMALE; FOLLOW UP; HUMAN; MALE; METASTASIS; NECK DISSECTION; POSTOPERATIVE CARE; PRIORITY JOURNAL; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY;

ADULT; AGED; BIOPSY, NEEDLE; CALCITONIN; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, MEDULLARY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; NEOPLASMS, MULTIPLE PRIMARY; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; THYROID GLAND; THYROID NEOPLASMS; THYROIDECTOMY; TUMOR MARKERS, BIOLOGICAL;

EID: 51449084894     PISSN: 14352443     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00423-008-0375-6     Document Type: Article

References (21)

1. A Machens S Hauptmann H Dralle 2007 Increased risk of lymph node metastasis in multifocal hereditary and sporadic medullary thyroid cancer World J Surg 31 1960 1965
2. RY Osamura O Yasuda T Kawakami Y Itoh K Inada K Kakudo 1997 Immunoelectron microscopic demonstration of regulated pathway for calcitonin and constitutive pathway for carcinoembryonic antigen in the same cells of human medullary carcinomas of thyroid glands Mod Pathol 10 7 11
3. ME Girelli D Nacamulli MR Pelizzo D De Vido C Mian M Piccolo B Busnardo 1998 Medullary thyroid carcinoma: clinical features and long-term follow-up of seventy-eight patients treated between 1969 and 1986 Thyroid 8 517 523
4. H Gharib WM McConahey RD Tiegs EJ Bergstralh JR Goellner CS Grant JA van Heerden GW Sizemore ID Hay 1992 Medullary thyroid carcinoma: clinicopathologic features and long-term follow-up of 65 patients treated during 1946 through 1970 Mayo Clin Proc 67 934 940
5. E Modigliani R Cohen JM Campos B Conte-Devolx B Maes A Boneu M Schlumberger JC Bigorgne P Dumontier L Leclerc B Corcuff I Guilhem 1998 Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'étude des tumeurs à calcitonine Clin Endocrinol 48 265 273
6. SA Hundahl B Cady MP Cunningham E Mazzaferri RF McKee J Rosai JP Shah AM Fremgen AK Stewart S Hölzer 2000 Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the united states during 1996. U.S. and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation study Cancer 89 202 217
7. JF Moley EA Fialkowski 2007 Evidence-based approach to the management of sporadic medullary thyroid carcinoma World J Surg 31 946 956
8. JF Moley MK DeBenedetti 1999 Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection Ann Surg 229 880 887
9. A Machens O Gimm J Ukkat R Hinze U Schneyer H Dralle 2000 Improved prediction of calcitonin normalization in medullary thyroid carcinoma patients by quantitative lymph node analysis Cancer 88 1909 1915
10. T Weber T Schilling K Frank-Raue M Colombo-Benkmann U Hinz R Ziegler E Klar 2001 Impact of modified radical neck dissection on biochemical cure in medullary thyroid carcinomas Surgery 130 1044 1049
11. C Scollo E Baudin JP Travagli B Caillou N Bellon S Leboulleux M Schlumberger 2003 Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer J Clin Endocrinol Metab 88 2070 2075
12. JB Fleming JE Lee M Bouvet PN Schultz SI Sherman RV Sellin KE Friend MA Burgess GJ Cote RF Gagel DB Evans 1999 Surgical strategy for the treatment of medullary thyroid carcinoma Ann Surg 230 697 707
13. O Gimm J Ukkat H Dralle 1998 Determinative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyroid carcinoma World J Surg 22 562 567
14. MR Pelizzo IM Boschin P Bernante A Toniato A Piotto C Pagetta O Nibale L Rampin PC Muzzio D Rubello 2007 Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients Eur J Surg Oncol 33 493 497
15. LE Tisell A Oden A Muth G Altiparmak J Mölne H Ahlman O Nilsson 2003 The Ki67 index a prognostic marker in medullary thyroid carcinoma Br J Cancer 89 2093 2097
16. A Laure Giraudet A Al Ghulzan A Aupérin S Leboulleux A Chehboun F Troalen C Dromain J Lumbroso E Baudin M Schlumberger 2008 Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times Eur J Endocrinol 158 239 246
17. TNM classification of malignant tumours (2002) Wiley-Liss, New York
18. B Busnardo ME Girelli N Simioni D Nacamulli E Busetto 1984 Nonparallel patterns of calcitonin and carcinoembryonic antigen levels in the follow-up of medullary thyroid carcinoma Cancer 53 278 285
19. SA Wells Jr DE Haagensen Jr WM Linehan RE Farrell WG Dilley 1978 The detection of elevated plasma levels of carcinoembryonic antigen in patients with suspected or established medullary thyroid carcinoma Cancer 42 1498 1503
20. A Machens J Ukkat S Hauptmann H Dralle 2007 Abnormal carcinoembryonic antigen levels and medullary thyroid cancer progression: a multivariate analysis Arch Surg 142 289 293
21. P Miccoli MN Minuto C Ugolini E Molinaro F Basolo P Berti A Pinchera R Elisei 2007 Clinically unpredictable prognostic factors in the outcome of medullary thyroid cancer Endocr Relat Cancer 14 1099 1105